Category: Globus MedicalSyndicate content

Globus, up on Q3 beat, surprises with CFO resignation

October 31, 2014 by Brad Perriello

Globus Medical shares gain on its better-than-forecast 3rd quarter as the orthopedics company announces the surprise resignation of CFO Richard Baron.

Globus, up on Q3 beat, surprises with CFO resignation

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A

October 29, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Globus Medical snaps up allograft maker Transplant Technologies

October 27, 2014 by Alexander Soule

Globus Medical acquires Transplant Technologies of Texas, a provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount.

Globus Medical snapes up allograft maker Transplant Technologies

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

J&J's Synthes wins another round against Globus, ex-sales rep

May 30, 2014 by Brad Perriello

A Pennsylvania judge bars a former Synthes USA sales rep from selling medical devices made by rival Globus Medical to his former Synthes customers.

J&J's Synthes wins another round against Globus, ex-sales rep

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Globus Medical posts a strong 1st quarter following robotic surgery entry

May 5, 2014 by Arezu Sarvestani

Globus Medical reports another strong quarter, with sales and profits up following the company's entry to the robotic surgery market.

Globus Medical posts a strong 1st quarter following robotic surgery entry

Globus Medical (NYSE:GMED) got some Wall Street love after reporting a strong 1st quarter, during which the company notched the acquisition of Excelsius Surgical.

Globus Medical gains a bit on strong Q4 prelims

January 15, 2014 by Brad Perriello

Globus Medical shares are up this morning on preliminary 4th-quarter sales numbers that topped expectations and blew away the sluggish overall spinal implant market.

Globus Medical gains a bit on strong Q4 prelims

Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street's expectations and sending share prices up today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Globus Medical gets into robotic surgery with Excelsius Surgical acquisition

January 9, 2014 by Brad Perriello

Globus Medical gets into the robotic surgery arena with the acquisition of Excelsius Surgical and its positioning platform for spine and brain procedures.

Globus Medical gets into robotic surgery with Excelsius Surgical acquisition
Globus Medical gets into robotic surgery with Excelsius Surgical acquisition

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp